ENDRA Life Sciences- Warrants (12/05/2022) Total Liabilities

As of the most recent data (June 2026), NDRAW shows a total liabilities of $1.6M. That compares with $1.3M in the prior-year period — up 22.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NDRAW's total liabilities is now $1.6M (was $1.3M) — a 22.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether ENDRA Life Sciences- Warrants (12/05/2022) is outperforming or lagging.

Tracking NDRAW's total liabilities over time shows whether ENDRA Life Sciences- Warrants (12/05/2022) is scaling, shrinking, or reshaping that part of the business. The current reading is $1.6M That compares with $1.3M in the prior-year period — up 22.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has ENDRA Life Sciences- Warrants (12/05/2022)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $1.6M) with ownership activity and broader fundamentals.

ENDRA Life Sciences- Warrants (12/05/2022)'s total liabilities is $1.6M; compare it with other Technology names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.